Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Movement Movement +8.01%
#3 COTI COTI +7.56%
#4 DMT-NAT DMT-NAT +7.27%
#5 Victoria VR Victoria VR +7.18%
#6 GRVT Token GRVT Token +4.67%
#7 Cryptopia Cryptopia +3.74%
#8 Kinetiq Kinetiq +3.53%
#9 Lisk Lisk +3.28%
#10 Jito Jito +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Pozycja w akcjach #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Cena akcji
$0.00023723
Ostatnia synchronizacja: 2024-08-26
Kapitalizacja rynkowa
$1.41K
Zmiana (1 dzień)
111.67%
Zmiana (1 rok)
0.00%
Kraj
FR
Handel Pharnext S.A. (ALPHA)

Kategoria

Healthcare
Zyski dla Pharnext S.A. (ALPHA)
Zyski w Dec 2023 TTM: $-31.69M
Według najnowszych raportów finansowych Pharnext S.A., obecny zysk firmy wynosi $-31.69M. W roku 2022 firma osiągnęła zysk w wysokości $-43.29M, spadek w porównaniu do zysku z roku 2021, który wynosił $-38.48M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Pharnext S.A. od 2013 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-31.69M 1.28%
2023 $-31.29M -27.73%
2022 $-43.29M 12.50%
2021 $-38.48M 30.75%
2020 $-29.43M -0.92%
2019 $-29.70M 21.26%
2018 $-24.50M -15.52%
2017 $-29.00M 29.32%
2016 $-22.42M 87.83%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -16,747.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -6,256.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -9,585.74%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR